An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections

Stopped Study was prematurely terminated due to administrative and strategic reasons

Conditions

• Urinary Tract Infection

Interventions

• DRUG: Flomoxef
• DRUG: Cefepime

Sponsor

Takeda